Literature DB >> 2665519

Sustained increases in plasma epinephrine concentration do not modulate renin release.

H M Yang1, T E Lohmeier, S D Kivlighn, R G Carroll, M J Smith.   

Abstract

We examined the relationship between plasma renin activity (PRA) and renal arterial pressure (RAP) during 1) control conditions, 2) acute, and 3) chronic intravenous epinephrine (EPI) infusion (125 ng.kg-1.min-1). In eight conscious uninephrectomized dogs maintained on a normal sodium intake, the renin stimulus-response curve (RSRC) was determined by a stepwise reduction in RAP with an inflatable occluder around the renal artery controlled by a servo unit. The RSRC could be approximated by two lines intersecting at a threshold pressure (approximately 20 mmHg below control RAP). In the high-pressure range, PRA was relatively insensitive to changes in RAP, whereas, below threshold pressure, changes in RAP had large effects on PRA. During acute EPI infusion there was approximately a 40% increase in heart rate (control = 57 +/- 3 beats/min) and hematocrit (control = 30 +/- 1%) in association with a rise in plasma EPI concentration from 73 +/- 16 to 1,413 +/- 100 pg/ml; mean arterial pressure (MAP) was unchanged (94 +/- 3 mmHg). Moreover, EPI acutely increased basal PRA from 0.3 +/- 0.1 to 0.8 +/- 0.3 ng angiotensin I.ml-1.h-1 and shifted the RSRC to the right (increasing threshold pressure 7 mmHg) without altering the slope of the RSRC curve either above or below threshold pressure. In contrast, although plasma EPI concentration and hematocrit remained elevated during chronic EPI infusion, heart rate and basal PRA returned to preinfusion values. In addition, there were no significant long-term changes in MAP or in any of the parameters of the RSRC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2665519     DOI: 10.1152/ajpendo.1989.257.1.E57

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Resetting of renal autoregulation in conscious dogs: angiotensin II and alpha1-adrenoceptors.

Authors:  P B Persson; H Ehmke; B Nafz; H R Kirchheim
Journal:  Pflugers Arch       Date:  1990-09       Impact factor: 3.657

Review 2.  Lowering of blood pressure by chronic suppression of central sympathetic outflow: insight from prolonged baroreflex activation.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  J Appl Physiol (1985)       Date:  2012-07-12

Review 3.  Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

Review 4.  Prolonged activation of the baroreflex: a viable approach for the treatment of hypertension?

Authors:  Thomas E Lohmeier; Austin M Barrett; Eric D Irwin
Journal:  Curr Hypertens Rep       Date:  2005-06       Impact factor: 5.369

Review 5.  Baroreflex activation: from mechanisms to therapy for cardiovascular disease.

Authors:  Radu Iliescu; Ionut Tudorancea; Thomas E Lohmeier
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.